Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007735 · ClinicalTrials.gov registry record · Phase 3
Antibiotic Treatment of Gulf War Veterans' Illnesses
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 450
- Enrollment target
NCT00007735 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 450 participants.
The verdict
NCT00007735, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 450 participants
- Enrollment target
Study Summary
In 1990 and 1991, the U.S. deployed approximately 700,000 troops to the Persian Gulf to liberate Kuwait from Iraqi occupation. While there were few casualties associated with the Gulf War, many individuals returned from this conflict with unexplained symptoms and illnesses. This constellation of symptoms has been termed Gulf War Veterans' Illnesses (GWI). Although several explanations have been offered as to the cause of GWI, none of the putative etiologic agents or conditions is currently supported by sufficient evidence. One explanation that has received fairly widespread attention is systemic Mycoplasma fermentans infection. It is the purpose of this study to determine if antibiotic treatment directed against Mycoplasma species (i.e. doxycycline) will improve functioning and symptoms in deployed Gulf War veterans with GWI.
Interventions
- DRUG Doxycycline (200mg/day) or Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 1999-01 |
| Est. Completion | 2001-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00007735
The ClinicalTrials.gov registry entry for NCT00007735 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Doxycycline (200mg/day) or Placebo is the first listed.
NCT00007735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00007735 about?
NCT00007735 is a clinical study titled "Antibiotic Treatment of Gulf War Veterans' Illnesses". In 1990 and 1991, the U.S. deployed approximately 700,000 troops to the Persian Gulf to liberate Kuwait from Iraqi occupation. While there were few casualties associated with the Gulf War, many individuals returned from this conflict with unexplained symptoms and illnesses. This constellation of sym...
What is the current status of trial NCT00007735?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 450 participants. The study started on 1999-01. Estimated completion is 2001-10.
What interventions are being tested in trial NCT00007735?
The interventions under investigation include: Doxycycline (200mg/day) or Placebo (DRUG).
Who is sponsoring clinical trial NCT00007735?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.